| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
|
| | Oc 144-093 Basic information |
| Product Name: | Oc 144-093 | | Synonyms: | ONT 093;4-[2-[4-[(E)-3-ethoxyprop-1-enyl]phenyl]-4-[4-(propan-2-ylamino)phenyl]-1H-imidazol-5-yl]-N-propan-2-ylaniline;OC144-093; OC-144-093;Benzenamine, 4-[2-[4-[(1E)-3-ethoxy-1-propen-1-yl]phenyl]-4-[4-[(1-methylethyl)amino]phenyl]-1H-imidazol-5-yl]-N-(1-methylethyl)-;4-(2-{4-[(1E)-3-ethoxyprop-1-en-1-yl]phenyl}-5-{4-[(propan-2-yl)amino]phenyl}-1H-imidazol-4-yl)-N-(propan-2-yl)aniline;(E)-4,4'-(2-(4-(3-Ethoxyprop-1-en-1-yl)phenyl)-1H-imidazole-4,5-diyl)bis(N-isopropylaniline);Oc 144-093 | | CAS: | 216227-54-2 | | MF: | C32H38N4O | | MW: | 494.67 | | EINECS: | | | Product Categories: | | | Mol File: | 216227-54-2.mol |  |
| | Oc 144-093 Chemical Properties |
| solubility | DMSO: soluble | | form | A crystalline solid | | color | Light yellow to yellow |
| | Oc 144-093 Usage And Synthesis |
| Uses | ONT-093 is a potent inhibitor of P-glycoprotein pump. ONT-093 has the potential for the research cancer diseases[1]. | | References | [1] Mistry P, et al. ONT-093 (Ontogen). Curr Opin Investig Drugs. 2002;3(11):1666-1671. PMID:12476971 |
| | Oc 144-093 Preparation Products And Raw materials |
|